Tycho Peterson's most recent trade in Adaptive Biotechnologies Corp was a trade of 147,790 Common Stock done . Disclosure was reported to the exchange on March 4, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 147,790 | 547,009 (0%) | 0% | 0 | Common Stock | |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.44 per share. | 04 Mar 2024 | 15,456 | 531,553 (0%) | 0% | 3.4 | 53,169 | Common Stock |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.30 per share. | 20 Jun 2023 | 134,961 | 534,180 (0%) | 0% | 7.3 | 985,215 | Common Stock |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2023 | 134,961 | 447,868 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.14 per share. | 20 Jun 2023 | 70,000 | 464,180 (0%) | 0% | 8.1 | 569,800 | Common Stock |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.14 per share. | 20 Jun 2023 | 64,961 | 399,219 (0%) | 0% | 8.1 | 528,783 | Common Stock |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 15 Jun 2023 | 55,672 | 399,219 (0%) | 0% | 8.5 | 474,882 | Common Stock |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 14,328 | 582,829 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 15 Jun 2023 | 14,328 | 399,219 (0%) | 0% | 8.5 | 122,218 | Common Stock |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.30 per share. | 15 Jun 2023 | 14,328 | 413,547 (0%) | 0% | 7.3 | 104,594 | Common Stock |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.16 per share. | 02 Jun 2023 | 38,000 | 454,891 (0%) | 0% | 7.2 | 272,080 | Common Stock |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 177,377 | 177,377 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 118,203 | 492,891 (0%) | 0% | 0 | Common Stock | |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 597,157 | 597,157 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 374,688 | 374,688 (0%) | 0% | 0 | Common Stock |